Daniel Tasse - 04 Jun 2021 Form 4 Insider Report for REGENXBIO Inc. (RGNX)

Role
Director
Signature
/s/ Patrick J. Christmas as attorney-in-fact
Issuer symbol
RGNX
Transactions as of
04 Jun 2021
Transactions value $
$0
Form type
4
Filing time
08 Jun 2021, 16:22:38 UTC
Next filing
24 Nov 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RGNX Stock Option (Right to Buy) Award $0 +10K $0.00 10K 04 Jun 2021 Common Stock 10K $35.52 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option will vest in 12 equal monthly installments following June 4, 2021.